ZA9510554B - Substituted 1H-imidazoles - Google Patents
Substituted 1H-imidazolesInfo
- Publication number
- ZA9510554B ZA9510554B ZA9510554A ZA9510554A ZA9510554B ZA 9510554 B ZA9510554 B ZA 9510554B ZA 9510554 A ZA9510554 A ZA 9510554A ZA 9510554 A ZA9510554 A ZA 9510554A ZA 9510554 B ZA9510554 B ZA 9510554B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425211.1A GB9425211D0 (en) | 1994-12-14 | 1994-12-14 | Substituted 1H-imidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9510554B true ZA9510554B (en) | 1996-06-13 |
Family
ID=10765918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9510554A ZA9510554B (en) | 1994-12-14 | 1995-12-12 | Substituted 1H-imidazoles |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5658938A (2) |
| EP (1) | EP0717037A1 (2) |
| JP (1) | JPH08208622A (2) |
| KR (1) | KR960022474A (2) |
| CN (1) | CN1054376C (2) |
| AR (1) | AR002257A1 (2) |
| AU (1) | AU693614B2 (2) |
| BG (1) | BG63043B1 (2) |
| BR (1) | BR9505815A (2) |
| CA (1) | CA2165133A1 (2) |
| CZ (1) | CZ327195A3 (2) |
| EE (1) | EE9500064A (2) |
| FI (1) | FI955927L (2) |
| GB (1) | GB9425211D0 (2) |
| HU (1) | HUT73980A (2) |
| IL (1) | IL116325A (2) |
| IS (1) | IS4311A (2) |
| MX (1) | MX9505063A (2) |
| NO (1) | NO305316B1 (2) |
| NZ (1) | NZ280646A (2) |
| PL (1) | PL311736A1 (2) |
| RO (1) | RO113346B1 (2) |
| RU (1) | RU2156239C2 (2) |
| SK (1) | SK155095A3 (2) |
| TW (1) | TW303362B (2) |
| ZA (1) | ZA9510554B (2) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
| GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| ZA981080B (en) | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| US20030073850A1 (en) * | 1998-08-07 | 2003-04-17 | Altenbach Robert J. | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use |
| US6388090B2 (en) | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
| AU5846901A (en) | 2000-05-08 | 2001-11-20 | Orion Corp | New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| TW200306783A (en) * | 2002-04-29 | 2003-12-01 | Fmc Corp | Pesticidal heterocycles |
| US20040266776A1 (en) * | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
| FI20022007A0 (fi) * | 2002-11-08 | 2002-11-08 | Juvantia Pharma Ltd Oy | Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi |
| FI20022159A0 (fi) * | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
| AU2007209382A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of CNS disorders |
| AU2007312390B2 (en) * | 2006-10-19 | 2013-03-28 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| JP5167265B2 (ja) * | 2006-10-19 | 2013-03-21 | エフ.ホフマン−ラ ロシュ アーゲー | 微量アミン関連受容体に親和性を有するアミノメチル−2−イミダゾール |
| CA2668454A1 (en) * | 2006-11-02 | 2008-05-08 | F. Hoffmann-La Roche Ag | Substituted 2-imidazoles |
| WO2008058867A2 (en) * | 2006-11-16 | 2008-05-22 | F. Hoffmann-La Roche Ag | Substituted 4-imidazoles |
| ES2364701T3 (es) * | 2006-12-13 | 2011-09-12 | F. Hoffmann-La Roche Ag | Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas. |
| US20080146523A1 (en) * | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| EP2114906B1 (en) | 2007-02-02 | 2014-08-06 | F. Hoffmann-La Roche AG | 2-aminooxazolines as taar1 ligands for cns disorders |
| MX2009008777A (es) * | 2007-02-13 | 2009-08-25 | Schering Corp | Derivados y analogos de cromano como agonistas de los receptores alfa2c adrenergicos funcionalmente selectivos. |
| WO2008100480A1 (en) * | 2007-02-13 | 2008-08-21 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| EP2125749A2 (en) * | 2007-02-13 | 2009-12-02 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| CA2676944C (en) * | 2007-02-15 | 2016-01-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolines as taar1 ligands |
| WO2009003868A2 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| AU2008270444A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| CA2694362A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| CA2695071A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of cns disorders |
| AU2008285795A1 (en) * | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands |
| CL2008003553A1 (es) * | 2007-12-05 | 2009-11-27 | Grindeks Jsc | Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso |
| WO2009105504A2 (en) | 2008-02-21 | 2009-08-27 | Schering Corporation | Functionally selective alpha2c adrenoreceptor agonists |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| RU2513086C2 (ru) * | 2008-07-24 | 2014-04-20 | Ф.Хоффманн-Ля Рош Аг | Производные 4,5-дигидро-оксазол-2-ила |
| EP2323734A1 (en) * | 2008-08-04 | 2011-05-25 | Schering Corporation | Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| EP2356106A1 (en) | 2008-10-07 | 2011-08-17 | Schering Corporation | Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US8673950B2 (en) | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
| US8802673B2 (en) | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
| US9073911B2 (en) | 2011-06-09 | 2015-07-07 | Hoffmann-La Roche Inc. | Pyrazole derivatives |
| US9029370B2 (en) | 2011-06-10 | 2015-05-12 | Hoffmann-La Roche Inc. | Substituted benzamide derivatives |
| JP5872069B2 (ja) | 2012-01-12 | 2016-03-01 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 微量アミン関連受容体(taar)としての複素環誘導体 |
| RS56747B1 (sr) | 2012-09-14 | 2018-03-30 | Hoffmann La Roche | Pirazol derivati karboksamida kao taar modulatori za upotrebu u lečenju nekoliko poremećaja, kao što su depresija, dijabetes i parkinsonova bolest |
| WO2014041106A1 (en) | 2012-09-17 | 2014-03-20 | F. Hoffmann-La Roche Ag | Triazole carboxamide derivatives |
| WO2015165085A1 (en) | 2014-04-30 | 2015-11-05 | F.Hoffmann-La Roche Ag | Morpholin-pyridine derivatives |
| MX2016016488A (es) | 2014-08-27 | 2017-03-30 | Hoffmann La Roche | Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar). |
| MX2016016190A (es) | 2014-08-27 | 2017-03-08 | Hoffmann La Roche | Derivados de pirazino[2,1-a]isoquinolina sustituida para el tratamiento de trastornos del sistema nervioso central. |
| WO2017157873A1 (en) | 2016-03-17 | 2017-09-21 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
| BR112018068688B1 (pt) * | 2016-03-17 | 2023-02-14 | Fmc Corporation | Processo para converter enantiômero s em sua forma racêmica, composto e uso do mesmo |
| CN116496261B (zh) * | 2023-03-09 | 2025-06-27 | 中国人民解放军军事科学院军事医学研究院 | 4-(1h)-咪唑类衍生物及其医药用途 |
| CN118684628B (zh) * | 2024-05-20 | 2025-06-17 | 中国人民解放军军事科学院军事医学研究院 | 取代二氢茚基咪唑类化合物及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6048972A (ja) * | 1983-08-25 | 1985-03-16 | Dai Ichi Seiyaku Co Ltd | テトラヒドロナフタレン誘導体 |
| GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB8626287D0 (en) * | 1986-11-04 | 1986-12-03 | Ucb Sa | Substituted 1h-imidazoles |
| GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| US5151526A (en) * | 1990-10-11 | 1992-09-29 | The United States Of America As Represented By The Secretary Of The Army | 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic |
| JPH04210680A (ja) * | 1990-12-01 | 1992-07-31 | Nissan Chem Ind Ltd | イミダゾール誘導体および植物生長調節剤 |
| GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
-
1994
- 1994-12-14 GB GBGB9425211.1A patent/GB9425211D0/en active Pending
-
1995
- 1995-12-05 MX MX9505063A patent/MX9505063A/es not_active IP Right Cessation
- 1995-12-08 PL PL95311736A patent/PL311736A1/xx unknown
- 1995-12-08 RO RO95-02138A patent/RO113346B1/ro unknown
- 1995-12-08 TW TW084113098A patent/TW303362B/zh active
- 1995-12-08 BG BG100208A patent/BG63043B1/bg unknown
- 1995-12-08 US US08/569,947 patent/US5658938A/en not_active Expired - Fee Related
- 1995-12-08 IS IS4311A patent/IS4311A/is unknown
- 1995-12-11 FI FI955927A patent/FI955927L/fi unknown
- 1995-12-11 IL IL11632595A patent/IL116325A/xx not_active IP Right Cessation
- 1995-12-11 SK SK1550-95A patent/SK155095A3/sk unknown
- 1995-12-11 NZ NZ280646A patent/NZ280646A/en unknown
- 1995-12-12 HU HU9503549A patent/HUT73980A/hu unknown
- 1995-12-12 CN CN95120834A patent/CN1054376C/zh not_active Expired - Fee Related
- 1995-12-12 ZA ZA9510554A patent/ZA9510554B/xx unknown
- 1995-12-12 NO NO955034A patent/NO305316B1/no not_active IP Right Cessation
- 1995-12-12 AR ARP950100512A patent/AR002257A1/es unknown
- 1995-12-12 AU AU40368/95A patent/AU693614B2/en not_active Ceased
- 1995-12-12 EE EE9500064A patent/EE9500064A/xx unknown
- 1995-12-12 CZ CZ953271A patent/CZ327195A3/cs unknown
- 1995-12-13 JP JP7324502A patent/JPH08208622A/ja active Pending
- 1995-12-13 RU RU95120582/04A patent/RU2156239C2/ru active
- 1995-12-13 BR BR9505815A patent/BR9505815A/pt not_active Application Discontinuation
- 1995-12-13 CA CA002165133A patent/CA2165133A1/en not_active Abandoned
- 1995-12-13 EP EP95870132A patent/EP0717037A1/fr not_active Withdrawn
- 1995-12-14 KR KR1019950049572A patent/KR960022474A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HUT73980A (en) | 1996-10-28 |
| CA2165133A1 (en) | 1996-06-15 |
| FI955927A7 (fi) | 1996-06-15 |
| BR9505815A (pt) | 1998-01-06 |
| EE9500064A (et) | 1996-06-17 |
| EP0717037A1 (fr) | 1996-06-19 |
| BG63043B1 (bg) | 2001-02-28 |
| CZ327195A3 (en) | 1996-07-17 |
| NO955034D0 (no) | 1995-12-12 |
| KR960022474A (ko) | 1996-07-18 |
| AR002257A1 (es) | 1998-03-11 |
| IL116325A0 (en) | 1996-03-31 |
| IS4311A (is) | 1996-06-15 |
| CN1133837A (zh) | 1996-10-23 |
| NZ280646A (en) | 1996-08-27 |
| AU693614B2 (en) | 1998-07-02 |
| RU2156239C2 (ru) | 2000-09-20 |
| MX9505063A (es) | 1997-01-31 |
| SK155095A3 (en) | 1997-02-05 |
| FI955927A0 (fi) | 1995-12-11 |
| PL311736A1 (en) | 1996-06-24 |
| JPH08208622A (ja) | 1996-08-13 |
| NO305316B1 (no) | 1999-05-10 |
| CN1054376C (zh) | 2000-07-12 |
| BG100208A (bg) | 1996-07-31 |
| TW303362B (2) | 1997-04-21 |
| RO113346B1 (ro) | 1998-06-30 |
| IL116325A (en) | 1999-10-28 |
| HU9503549D0 (en) | 1996-02-28 |
| FI955927L (fi) | 1996-06-15 |
| GB9425211D0 (en) | 1995-02-15 |
| US5658938A (en) | 1997-08-19 |
| NO955034L (no) | 1996-06-17 |
| AU4036895A (en) | 1996-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69530493D1 (en) | Ablationsgerät | |
| DE69512030D1 (en) | Cerebral-dilator | |
| ZA9510554B (en) | Substituted 1H-imidazoles | |
| DE59503739D1 (en) | Polymer-sensor | |
| EP0778836A4 (en) | 9-SUBSTITUTED ALKYLADENINS | |
| DE69529159D1 (en) | Hüftgelenkprothese | |
| DE69504528D1 (en) | Quenchkühler | |
| DE69502271D1 (en) | Afterabtrennung | |
| DE69511086D1 (en) | Pyrimidinderivate | |
| DE69429543D1 (en) | Koagulationszange | |
| DE59503634D1 (en) | Friercontainer | |
| HU9502378D0 (en) | Substituted biphenyl-oxazolinones | |
| ZA954095B (en) | Substituted 3-phenylpyrazoles | |
| DE59509661D1 (en) | Heterocyclylbenzonitrile | |
| ZA956011B (en) | Substituted triazolylmethylphenylnaphthyridones | |
| ZA954546B (en) | Substituted 3-phenylpyrazoles | |
| AU122938S (en) | Breadbox | |
| DE69517588D1 (en) | Gekühlter transportcontainer | |
| DE69517886D1 (en) | Spiropyranverbindung | |
| DE69508761D1 (en) | Haloalkylierungsverfahren | |
| DE69527047D1 (en) | Bisazoverbindung | |
| DE69506730D1 (en) | Differentialer antriebsmechanismus | |
| DE59508136D1 (en) | Phenylthio-oxazolin-derivate | |
| ZA951092B (en) | Substituted oxazacycloalkenes | |
| DE69502834D1 (en) | Vinylperfluorcyclopropanpolymere |